Company: IMNN
Filing Date: 2025-05-19
Form Type: S-1/A
Source: 0001641172-25-011388
Chunk: 41

Company: Imunon, Inc.
Filing Date: 2025-05-19
Form: S-1/A
Chunk 41
---
 of (x) the lowest Event Market Price with respect to any                
 Share Combination Event that occurred prior to Stockholder Approval being obtained, and (y)             
 the price determined by reference to clause (ii) of the definition of Floor Price. If one               
 or more Share Combination Events occurs prior to Stockholder Approval being obtained and                
 the reduction of the exercise price to the Event Market Price, once Stockholder Approval                
 is obtained, the exercise price will automatically be reduced to the lowest Event Market                
 Price with respect to any Share Combination Event that occurred prior to Stockholder Approval           
 being obtained and the Share Combination Issuable Shares will automatically be adjusted to              
 equal the highest such number with respect to any Share Combination Event that occurred prior           
 to Stockholder Approval being obtained, provided that in no event will the exercise price               
 be reduced below the Floor Price. Notwithstanding the foregoing, the number of shares                   
 potentially issuable upon exercise of the common warrants is limited by the number of available         
 shares of authorized Common Stock; accordingly, the aggregate number of shares of Common                
 Stock potentially issuable in this offering is limited to a total of 90,000,000 shares of               
 Common Stock, with the number of shares of Common Stock potentially issuable upon exercise              
 of the common warrants determined by subtracting the aggregate number of shares of Common               
 Stock or pre-funded warrants issued in this offering from 90,000,000 shares. Each purchaser             
 will receive a pro rata portion of such amount. As a result, the aggregate number of                    
 shares of Common Stock underlying all of the common warrants may increase from 16,666,667               
 up to 73,333,333 (in each case, based on an assumed public offering price of $0.48                      
 per share), assuming full adjustment of the exercise price to the Floor Price and giving                
 effect to the “zero exercise price” provision.                                                          |

| ● | Voluntary                                                                               
 Adjustment of Exercise Price: Subject                                                   
 to the rules and regulations of Nasdaq, the Company may at any time during the term     
 of the common warrants, with the prior written consent of the holders of the common     
 warrants representing at least a majority of the shares of Common Stock then underlying 
 the common warrants, reduce the then current exercise price of the common warrants      
 to any amount and for any period of time deemed appropriate by the board of directors   
 of the Company.                                                                         |

“ Adjustment Date” means the close of trading on the 11th trading day after the trading day during which the